Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the COVID-19 crisis on imaging in oncological trials.
Deroose CM, Lecouvet FE, Collette L, Oprea-Lager DE, Kunz WG, Bidaut L, Verhoeff JJC, Caramella C, Lopci E, Tombal B, de Geus-Oei LF, Fournier L, Smits M, deSouza NM. Deroose CM, et al. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2054-2058. doi: 10.1007/s00259-020-04910-y. Eur J Nucl Med Mol Imaging. 2020. PMID: 32533240 Free PMC article. No abstract available.
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.
Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot JN, Zacho H, Tombal B, deSouza NM. Lecouvet FE, et al. Lancet Oncol. 2018 Oct;19(10):e534-e545. doi: 10.1016/S1470-2045(18)30571-0. Epub 2018 Oct 1. Lancet Oncol. 2018. PMID: 30303127 Review.
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.
Fanti S, Goffin K, Hadaschik BA, Herrmann K, Maurer T, MacLennan S, Oprea-Lager DE, Oyen WJ, Rouvière O, Mottet N, Bjartell A. Fanti S, et al. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):469-476. doi: 10.1007/s00259-020-04934-4. Epub 2020 Jul 2. Eur J Nucl Med Mol Imaging. 2021. PMID: 32617640 Free PMC article.
Cylindroma, an uncommon presentation on 18F-DCFPyL PET/CT.
Koene BPF, Bodar YJL, Meijer D, Jaspars EH, Vis AN, Oprea-Lager DE. Koene BPF, et al. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):927-928. doi: 10.1007/s00259-020-04943-3. Epub 2020 Jul 11. Eur J Nucl Med Mol Imaging. 2021. PMID: 32654067 Free PMC article. No abstract available.
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.
Fournier L, Costaridou L, Bidaut L, Michoux N, Lecouvet FE, de Geus-Oei LF, Boellaard R, Oprea-Lager DE, Obuchowski NA, Caroli A, Kunz WG, Oei EH, O'Connor JPB, Mayerhoefer ME, Franca M, Alberich-Bayarri A, Deroose CM, Loewe C, Manniesing R, Caramella C, Lopci E, Lassau N, Persson A, Achten R, Rosendahl K, Clement O, Kotter E, Golay X, Smits M, Dewey M, Sullivan DC, van der Lugt A, deSouza NM, European Society Of Radiology. Fournier L, et al. Eur Radiol. 2021 Aug;31(8):6001-6012. doi: 10.1007/s00330-020-07598-8. Epub 2021 Jan 25. Eur Radiol. 2021. PMID: 33492473 Free PMC article.
Correction to: Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.
Fournier L, Costaridou L, Bidaut L, Michoux N, Lecouvet FE, de Geus-Oei LF, Boellaard R, Oprea-Lager DE, Obuchowski NA, Caroli A, Kunz WG, Oei EH, O'Connor JPB, Mayerhoefer ME, Franca M, Alberich-Bayarri A, Deroose CM, Loewe C, Manniesing R, Caramella C, Lopci E, Lassau N, Persson A, Achten R, Rosendahl K, Clement O, Kotter E, Golay X, Smits M, Dewey M, Sullivan DC, van der Lugt A, deSouza NM; European Society of Radiology. Fournier L, et al. Eur Radiol. 2021 Aug;31(8):6408-6409. doi: 10.1007/s00330-021-07721-3. Eur Radiol. 2021. PMID: 33693997 Free PMC article. No abstract available.
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
Bodar YJL, Zwezerijnen BGJC, van der Voorn PJ, Jansen BHE, Smit RS, Kol SQ, Meijer D, de Bie K, Yaqub M, Windhorst BAD, Hendrikse HNH, Vis AN, Oprea-Lager DE. Bodar YJL, et al. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1731-1742. doi: 10.1007/s00259-021-05604-9. Epub 2021 Nov 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34725727 Free PMC article.
127 results